[1-[3-[[9-[5-(4-tert-butylphenyl)-4-methyl-2-pyridinyl]-1H-carbazol-1-id-2-yl]oxy]benzene-2-id-1-yl]-3-(6-oxo-1,3-diphenyl-7,8-dihydro-5H-naphthalen-2-yl)benzimidazol-2-ylidene]platinum

C63H48N4O2Pt-2 — CID 171056703

IUPAC[1-[3-[[9-[5-(4-tert-butylphenyl)-4-methyl-2-pyridinyl]-1H-carbazol-1-id-2-yl]oxy]benzene-2-id-1-yl]-3-(6-oxo-1,3-diphenyl-7,8-dihydro-5H-naphthalen-2-yl)benzimidazol-2-ylidene]platinum
SMILESCc1cc(-n2c3[c-]c(Oc4[c-]c(-n5c(=[Pt])n(-c6c(-c7ccccc7)cc7c(c6-c6ccccc6)CCC(=O)C7)c6ccccc65)ccc4)ccc3c3ccccc32)ncc1-c1ccc(C(C)(C)C)cc1
InChIInChI=1S/C63H48N4O2.Pt/c1-41-34-60(64-39-55(41)43-26-28-46(29-27-43)63(2,3)4)67-56-23-12-11-22-52(56)53-33-31-50(38-59(53)67)69-49-21-15-20-47(37-49)65-40-66(58-25-14-13-24-57(58)65)62-54(42-16-7-5-8-17-42)36-45-35-48(68)30-32-51(45)61(62)44-18-9-6-10-19-44;/h5-29,31,33-34,36,39H,30,32,35H2,1-4H3;/q-2;
InChIKeyQVKMBCNHLMUZCU-UHFFFAOYSA-N
MW1088.18 g/mol
LogP15.05
Rot. Bonds8

About [1-[3-[[9-[5-(4-tert-butylphenyl)-4-methyl-2-pyridinyl]-1H-carbazol-1-id-2-yl]oxy]benzene-2-id-1-yl]-3-(6-oxo-1,3-diphenyl-7,8-dihydro-5H-naphthalen-2-yl)benzimidazol-2-ylidene]platinum

[1-[3-[[9-[5-(4-tert-butylphenyl)-4-methyl-2-pyridinyl]-1H-carbazol-1-id-2-yl]oxy]benzene-2-id-1-yl]-3-(6-oxo-1,3-diphenyl-7,8-dihydro-5H-naphthalen-2-yl)benzimidazol-2-ylidene]platinum (PubChem CID 171056703) has the molecular formula C63H48N4O2Pt-2 and a molecular weight of 1088.18 g/mol. Its IUPAC name is [1-[3-[[9-[5-(4-tert-butylphenyl)-4-methyl-2-pyridinyl]-1H-carbazol-1-id-2-yl]oxy]benzene-2-id-1-yl]-3-(6-oxo-1,3-diphenyl-7,8-dihydro-5H-naphthalen-2-yl)benzimidazol-2-ylidene]platinum.

Molecular Properties

Compound Name[1-[3-[[9-[5-(4-tert-butylphenyl)-4-methyl-2-pyridinyl]-1H-carbazol-1-id-2-yl]oxy]benzene-2-id-1-yl]-3-(6-oxo-1,3-diphenyl-7,8-dihydro-5H-naphthalen-2-yl)benzimidazol-2-ylidene]platinum
PubChem CID171056703
Molecular FormulaC63H48N4O2Pt-2
Molecular Weight1088.18 g/mol
Exact Mass1087.34
IUPAC Name[1-[3-[[9-[5-(4-tert-butylphenyl)-4-methyl-2-pyridinyl]-1H-carbazol-1-id-2-yl]oxy]benzene-2-id-1-yl]-3-(6-oxo-1,3-diphenyl-7,8-dihydro-5H-naphthalen-2-yl)benzimidazol-2-ylidene]platinum
SMILESCc1cc(-n2c3[c-]c(Oc4[c-]c(-n5c(=[Pt])n(-c6c(-c7ccccc7)cc7c(c6-c6ccccc6)CCC(=O)C7)c6ccccc65)ccc4)ccc3c3ccccc32)ncc1-c1ccc(C(C)(C)C)cc1
InChIInChI=1S/C63H48N4O2.Pt/c1-41-34-60(64-39-55(41)43-26-28-46(29-27-43)63(2,3)4)67-56-23-12-11-22-52(56)53-33-31-50(38-59(53)67)69-49-21-15-20-47(37-49)65-40-66(58-25-14-13-24-57(58)65)62-54(42-16-7-5-8-17-42)36-45-35-48(68)30-32-51(45)61(62)44-18-9-6-10-19-44;/h5-29,31,33-34,36,39H,30,32,35H2,1-4H3;/q-2;
InChIKeyQVKMBCNHLMUZCU-UHFFFAOYSA-N
XLogP15.05
TPSA53.98 Ų
H-Bond Donors
H-Bond Acceptors6
Rotatable Bonds8
Heavy Atoms70
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 5001088.18
LogP ≤ 515.05
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 106

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}

Analyze [1-[3-[[9-[5-(4-tert-butylphenyl)-4-methyl-2-pyridinyl]-1H-carbazol-1-id-2-yl]oxy]benzene-2-id-1-yl]-3-(6-oxo-1,3-diphenyl-7,8-dihydro-5H-naphthalen-2-yl)benzimidazol-2-ylidene]platinum with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [1-[3-[[9-[5-(4-tert-butylphenyl)-4-methyl-2-pyridinyl]-1H-carbazol-1-id-2-yl]oxy]benzene-2-id-1-yl]-3-(6-oxo-1,3-diphenyl-7,8-dihydro-5H-naphthalen-2-yl)benzimidazol-2-ylidene]platinum?
The IUPAC name of [1-[3-[[9-[5-(4-tert-butylphenyl)-4-methyl-2-pyridinyl]-1H-carbazol-1-id-2-yl]oxy]benzene-2-id-1-yl]-3-(6-oxo-1,3-diphenyl-7,8-dihydro-5H-naphthalen-2-yl)benzimidazol-2-ylidene]platinum (CID 171056703) is [1-[3-[[9-[5-(4-tert-butylphenyl)-4-methyl-2-pyridinyl]-1H-carbazol-1-id-2-yl]oxy]benzene-2-id-1-yl]-3-(6-oxo-1,3-diphenyl-7,8-dihydro-5H-naphthalen-2-yl)benzimidazol-2-ylidene]platinum.
What is the SMILES notation for [1-[3-[[9-[5-(4-tert-butylphenyl)-4-methyl-2-pyridinyl]-1H-carbazol-1-id-2-yl]oxy]benzene-2-id-1-yl]-3-(6-oxo-1,3-diphenyl-7,8-dihydro-5H-naphthalen-2-yl)benzimidazol-2-ylidene]platinum?
The canonical SMILES for [1-[3-[[9-[5-(4-tert-butylphenyl)-4-methyl-2-pyridinyl]-1H-carbazol-1-id-2-yl]oxy]benzene-2-id-1-yl]-3-(6-oxo-1,3-diphenyl-7,8-dihydro-5H-naphthalen-2-yl)benzimidazol-2-ylidene]platinum is Cc1cc(-n2c3[c-]c(Oc4[c-]c(-n5c(=[Pt])n(-c6c(-c7ccccc7)cc7c(c6-c6ccccc6)CCC(=O)C7)c6ccccc65)ccc4)ccc3c3ccccc32)ncc1-c1ccc(C(C)(C)C)cc1.
What is the InChIKey of [1-[3-[[9-[5-(4-tert-butylphenyl)-4-methyl-2-pyridinyl]-1H-carbazol-1-id-2-yl]oxy]benzene-2-id-1-yl]-3-(6-oxo-1,3-diphenyl-7,8-dihydro-5H-naphthalen-2-yl)benzimidazol-2-ylidene]platinum?
The InChIKey is QVKMBCNHLMUZCU-UHFFFAOYSA-N. The full InChI is InChI=1S/C63H48N4O2.Pt/c1-41-34-60(64-39-55(41)43-26-28-46(29-27-43)63(2,3)4)67-56-23-12-11-22-52(56)53-33-31-50(38-59(53)67)69-49-21-15-20-47(37-49)65-40-66(58-25-14-13-24-57(58)65)62-54(42-16-7-5-8-17-42)36-45-35-48(68)30-32-51(45)61(62)44-18-9-6-10-19-44;/h5-29,31,33-34,36,39H,30,32,35H2,1-4H3;/q-2;.
What are the key properties of [1-[3-[[9-[5-(4-tert-butylphenyl)-4-methyl-2-pyridinyl]-1H-carbazol-1-id-2-yl]oxy]benzene-2-id-1-yl]-3-(6-oxo-1,3-diphenyl-7,8-dihydro-5H-naphthalen-2-yl)benzimidazol-2-ylidene]platinum?
[1-[3-[[9-[5-(4-tert-butylphenyl)-4-methyl-2-pyridinyl]-1H-carbazol-1-id-2-yl]oxy]benzene-2-id-1-yl]-3-(6-oxo-1,3-diphenyl-7,8-dihydro-5H-naphthalen-2-yl)benzimidazol-2-ylidene]platinum has a molecular weight of 1088.18 g/mol, XLogP of 15.05, 8 rotatable bonds, 0 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for [1-[3-[[9-[5-(4-tert-butylphenyl)-4-methyl-2-pyridinyl]-1H-carbazol-1-id-2-yl]oxy]benzene-2-id-1-yl]-3-(6-oxo-1,3-diphenyl-7,8-dihydro-5H-naphthalen-2-yl)benzimidazol-2-ylidene]platinum is sourced from PubChem (CID 171056703), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).